Skip to main content
NCD 150.6 · version 1

NCD 150.6: Vitamin B12 Injections to Strengthen Tendons, Ligaments, etc., of the Foot

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 150.6

Benefit category
Drugs and Biologicals
Effective date
Longstanding NCD
Date of this version not posted by CMS
Transmittal
n/a
Versions published
1
Manual section
150
Musculoskeletal System, NCD Manual (Pub. 100-03) chapter 1 part 2

TL;DR

NCD 150.6 sets Medicare's national policy for vitamin b12 injections to strengthen tendons, ligaments, etc., of the foot under the benefit category "Drugs and Biologicals", as a longstanding NCD (CMS has not posted the effective date of its current version). Vitamin B12 injections to strengthen tendons, ligaments, etc., of the foot are not covered under Medicare because (1) there is no evidence that vitamin B12 injections are effective for the purpose of strengthening weakened tendons and ligaments, and (2) this… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

Vitamin B12 injections to strengthen tendons, ligaments, etc., of the foot are not covered under Medicare because (1) there is no evidence that vitamin B12 injections are effective for the purpose of strengthening weakened tendons and ligaments, and (2) this is nonsurgical treatment under the subluxation exclusion. Accordingly, vitamin B12 injections are not considered reasonable and necessary within the meaning of §1862(a)(1) of the Act.

Text reproduced from the CMS Medicare Coverage Database record for NCD 150.6 version 1. View the original on cms.gov.

Local policies that build on this NCD

7 active Local Coverage Determinations cite NCD 150.6 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

  • Peripheral Nerve Injections and Procedures for Chronic Pain (L40300) · Wisconsin Physicians Service Insurance Corporation
  • L33967 Vitamin B<sub>12</sub> Injections · First Coast Service Options, Inc.
  • L35249 Nerve Blocks for Peripheral Neuropathy · CGS Administrators, LLC
  • L40261 Peripheral Nerve Injections and Procedures for Chronic Pain · CGS Administrators, LLC
  • L40263 Peripheral Nerve Injections and Procedures for Chronic Pain · Palmetto GBA
  • L40265 Peripheral Nerve Injections and Procedures for Chronic Pain · Noridian Healthcare Solutions, LLC
  • L40267 Peripheral Nerve Injections and Procedures for Chronic Pain · Wellpoint Federal

How MACs bill NCD 150.6

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 150.6, from 1 contractor. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 150.6
ContractorArticles
CGS Administrators, LLCA57663

A57663: Billing and Coding: Nerve Blocks for Peripheral Neuropathy

Billing and Coding, effective 2026-05-07 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

No covered diagnosis list, 102 non-covered; 9 procedure codes: 64450, 76881, 76882, 76942, 76999, 97032, 97139, G0282, G0283. Local policy: L35249 Nerve Blocks for Peripheral Neuropathy. Check a diagnosis for 64450.

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 150.6

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 150.6

What does NCD 150.6 cover?

Vitamin B12 injections to strengthen tendons, ligaments, etc., of the foot are not covered under Medicare because (1) there is no evidence that vitamin B12 injections are effective for the purpose of strengthening weakened tendons and ligaments, and (2) this is nonsurgical treatment under the subluxation exclusion. Accordingly, vitamin B12 injections are not considered reasonable and necessary within the meaning… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 150.6 take effect?

NCD 150.6 is a longstanding NCD (CMS has not posted the effective date of its current version); the current version is 1. This is the only published version.

Does a Local Coverage Determination override NCD 150.6?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.